LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Could melatonin have a potential adjuvant role in the treatment of the lasting anosmia associated with COVID‐19? A review

Photo from wikipedia

Anosmia, the loss of the sense of smell, is usually associated with rhinopathies and has been reported as a common symptom of COVID‐19. There is no specific drug to treat… Click to show full abstract

Anosmia, the loss of the sense of smell, is usually associated with rhinopathies and has been reported as a common symptom of COVID‐19. There is no specific drug to treat this condition, although some evidence suggests that melatonin could promote the recovery of olfactory sensory neurons.

Keywords: could melatonin; role treatment; treatment lasting; adjuvant role; melatonin potential; potential adjuvant

Journal Title: International Journal of Developmental Neuroscience
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.